Mellitus is developing a novel in vitro diagnostic test for the measurement of Glycated CD59 (GCD59) with potential clinical utility in screening, diagnosis and monitoring of diabetes, stratification of complications risk and as a clinical trial test for pharmaceutical development. Mellitus' lead product candidate is a test for Gestational Diabetes Mellitus (GDM).

Medical Devices

Mellitus

John Tagliamonte

Shailendra Kumar, Ph.D

Michael Chorev

Christopher de Souza

Kathy Welch

Rick Saul

The founding team at Mellitus has a wealth of experience in management and founding companies, as well as a background in biology from Emmanuel College (Boston) and Simmons University. This team is uniquely positioned to create a successful company in the healthcare industry.

Founding Team

Board of Directors

Leadership Team

Founding Team

About

Team members

Other teams at Mellitus

Board of Directors

Leadership Team